|
|
 |
|
HGSI: Human Genome Sciences Inc - Stock News |
Enter Ticker:
|
|
| Nov 18, 2009 |
Human Genome Gets FDA Response Letter for Raxibacumab Biologics License Application |
| Nov 18, 2009 |
HGSI's ABthrax Faces FDA Delay |
| Nov 16, 2009 |
Human Genome Sciences Receives Complete Response Letter from FDA for Raxibacumab Biologics License Application |
| Nov 12, 2009 |
Trading Outlook for ZymoGenetics Inc. Issued by StockPreacher.com |
| Nov 11, 2009 |
BenchmarkJournal.com Issues Independent Review on PAET, AKAM, CERN,INFY, HGSI and ALKS |
| Nov 10, 2009 |
Chart of the Day for Tue Nov 10th 2009 |
| Nov 09, 2009 |
Emerging Stock Report Initiates Independent Research Coverage On Human Genome Sciences |
| Nov 04, 2009 |
Market Pulse Breaking News Alert for Wednesday, November 4, 2009:SOAN -- So Act Network Announces Selection of Adobe SystemsAcquisition Omniture to Integrate Data From Social Action Media Site! |
| Nov 03, 2009 |
Playing Leapfrog with the 50 DMA |
| Nov 02, 2009 |
Choppy Session Ends Positive |
| Nov 02, 2009 |
Today's Big Gainers: Encore Acquistion Company, Human Genome Sciences |
| Nov 02, 2009 |
Stock-PR.com Announces Daily Stock Watch: NVAX, HGSI, AMGN |
| Nov 02, 2009 |
Dr. Stockpick Announces Daily Stock Watch - AMLN, VRTX, HGSI |
| Nov 02, 2009 |
Crown Equity Holdings, Inc.: CRWENews Highlights: HGSI, SNY |
| Oct 31, 2009 |
FDA Panel Seeks ABthrax Data |
| |
| ZACKS COMMENTARY FOR HGSI |
| Nov 17, 2009 | Zacks Blog: HGSI’s ABthrax Faces FDA Delay | | Nov 17, 2009 | Zacks Equity Research: Report for HGSI | | Nov 05, 2009 | Zacks Blog: Lower Q3 Loss for Human Genome | | Oct 30, 2009 | Zacks Blog: FDA Panel Seeks ABthrax Data | | Oct 28, 2009 | Zacks Blog: HGSI Drug Under FDA Review | | Sep 28, 2009 | Zacks Blog: Benlysta Should Be a Blockbuster | | Jul 30, 2009 | Zacks Blog: Human Genome Revises Offering | | Jul 29, 2009 | Zacks Blog: Human Genome Raising Money | | Jul 23, 2009 | Zacks Blog: Lower Q2 Loss for Human Genome | | Jul 23, 2009 | Zacks Blog: Zacks Analyst Blog Highlights: Morgan Stanley, Goldman Sachs, JP Morgan, Human Genome Sciences, Inc. and GlaxoSmithKline Plc | | Jul 22, 2009 | Zacks Blog: Human Genome Gets ABthrax Order | | Jul 20, 2009 | Zacks Blog: Human Genome Achieves BLISS |
|
|
Sponsored Links 
0.16